Sufen Li , Xianyu Bian , Jianxin Wang , Dandan Wang , Jinzhu Zhou , Jiapeng Song , Wei Wang , Nan Han , Junming Zhou , Yunchuan Li , Ran Tao , Xuejiao Zhu , Baochao Fan , Hailong Dong , Xuehan Zhang , Bin Li
{"title":"VP4-Specific IgA level as a correlate of neutralizing antibody and fecal shedding of porcine rotavirus infection","authors":"Sufen Li , Xianyu Bian , Jianxin Wang , Dandan Wang , Jinzhu Zhou , Jiapeng Song , Wei Wang , Nan Han , Junming Zhou , Yunchuan Li , Ran Tao , Xuejiao Zhu , Baochao Fan , Hailong Dong , Xuehan Zhang , Bin Li","doi":"10.1016/j.vetmic.2025.110501","DOIUrl":null,"url":null,"abstract":"<div><div>Rotavirus (RV) causes diarrhea in children, infants, and young animals globally, with public health implications. Porcine rotavirus (PoRV) leads to economic losses in swine farming. Neutralizing antibodies (NAb) are vital for protecting piglets from intestinal infections. However, which serum and mucosal markers correlate with NAbs against PoRV and relate to post-infection fecal shedding remains unclear, crucial for pathogen-specific detection. We used indirect ELISA to measure IgG/IgA in sera, sIgA in colostrum from recovered pigs, and feces from diarrheal piglets against VP4*, VP7*, VP6, and NSP4*. Analyses showed specific IgA/sIgA levels correlated better with NAb titers than IgG. Among them, VP4*-specific IgA/sIgA had the highest positive correlation with NAb titers in sera (R = 0.848, P < 0.0001) and colostrum (R = 0.865, P < 0.0001). Also, VP4*-specific IgA/sIgA in sera (R= −0.446, P < 0.001) and feces (R= −0.497, P < 0.0001) had the strongest inverse relationship with viral RNA load. Piglet passive protection tests confirmed VP4*-specific IgA's high neutralizing capacity, highly correlated with NAb titers (R = 0.858, P < 0.0001), reducing viral shedding. In conclusion, mucosal IgA/sIgA responses to VP4 are important for PoRV diagnosis assays and vaccine efficacy evaluation.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"304 ","pages":"Article 110501"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525001361","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Rotavirus (RV) causes diarrhea in children, infants, and young animals globally, with public health implications. Porcine rotavirus (PoRV) leads to economic losses in swine farming. Neutralizing antibodies (NAb) are vital for protecting piglets from intestinal infections. However, which serum and mucosal markers correlate with NAbs against PoRV and relate to post-infection fecal shedding remains unclear, crucial for pathogen-specific detection. We used indirect ELISA to measure IgG/IgA in sera, sIgA in colostrum from recovered pigs, and feces from diarrheal piglets against VP4*, VP7*, VP6, and NSP4*. Analyses showed specific IgA/sIgA levels correlated better with NAb titers than IgG. Among them, VP4*-specific IgA/sIgA had the highest positive correlation with NAb titers in sera (R = 0.848, P < 0.0001) and colostrum (R = 0.865, P < 0.0001). Also, VP4*-specific IgA/sIgA in sera (R= −0.446, P < 0.001) and feces (R= −0.497, P < 0.0001) had the strongest inverse relationship with viral RNA load. Piglet passive protection tests confirmed VP4*-specific IgA's high neutralizing capacity, highly correlated with NAb titers (R = 0.858, P < 0.0001), reducing viral shedding. In conclusion, mucosal IgA/sIgA responses to VP4 are important for PoRV diagnosis assays and vaccine efficacy evaluation.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.